§ 112.02 SYNTHETIC ALTERNATIVE DRUGS.
   (A)   Definitions. For the purpose of this section, the following definitions apply unless the context clearly indicates or requires a different meaning.
      SYNTHETIC CANNABINOID. Any laboratory-created compound that functions similarly to the active ingredient in marijuana, tetrahydrocannabinol (THC), including, but not limited to, any quantity of a natural or synthetic material, compound, mixture, preparation, substance, and its analog containing a cannabinoid receptor agonist, such as:
         (a)   JWH-007 (1-pentyl-2-methyl-3(1-naphthoyl)indole);
         (b)   JWH-015 ((2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenylmethanone);
         (c)   JWH-018 (1-pentyl-3-(1-naphthoyl)indole);
         (d)   JWH-019 (1-hexyl-3-(naphthalen-1-oyl)indole);
         (e)   JWH-073 (naphthalen-1-yl-(1-butylindol-3-yl)methanone);
         (f)   JWH-081 (4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone);
         (g)   JWH-098 (4-methoxynaphthalen-1-yl-(1-pentyl-2-Methylindol-3-yl)methanone);
         (h)   JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole);
         (i)   JWH-164 (7-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone;
         (j)   JWH-200 (1-(2-morpholin-4-ylethyl)indol-3-yl)naphthalen-1-ylmethuanone);
         (k)   JWH-203 (2-(2-chlorophenyl-1-(1-pentylindol-3-yl)ethanone;
         (l)   JWH-210 (4-ethylnaphthalen-1-yl-(1-pentylindol-3-yl)methanone;
         (m)   JWH-250 (1-pentyl-3-(2-methoxyphenylacetyl)indole);
         (n)   JWH-251 (1-pentyl-3-(2-methylphenylacetyl)indole);
         (o)   JWH-398 (1-pentyl-3-(4-chloro-l-naphthoyl)indole);
         (p)   HU-210 ((6aR,10aR-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10, 10a-tetrahydrobenzo [c]chromen-1-01);
         (q)   HU-211 ((6aS, 10aS)-9-(Hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-6a, 7, 10, 10a tetrahydrobenzo [c]chromen-1-ol);
         (r)   HU-308 ([1R, 2R, 5R)-2-[2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl]-7, 7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]methanol);
         (s)   HU-331 ((3-hydroxy-2-[(1R, 6R)-3-methyl-6-(1-methlethenyl)-2-cyclohexen-1-yl] -5-pentyl-2, 5-cyclohexadiene-1,4-dione);
         (t)   CP 55,940 (2-[(1R, 2R, 5R)-5-hydroxy-2-(3-hydroxpropyl) cyclohexyl]-5- (2-methloctan-2-yl)phenol;
         (u)   CP 47,497 (2-[1R,3S)-3-hydroxycyclophexyl]-5-(2-methyloctan-2-yl)phenol) and its homologues;
         (v)   WIN 55,212-2((R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo [1,2,3-de)-1,4-benzoxazin-6-6yl]-1-nephalenylmethanone);
         (w)   RCS-4 ((4-methoxphenyl)(1-pentyl-1H-indol-3-yl) methanone); or
         (x)   RCS-8 (1-(1-(2-cyclohexylethyl)-1H-indol-3-yl)-2-(2-methoxyphenyl)ethanone).
      SYNTHETIC STIMULANT. Any compound which is a federally controlled Schedule I substance, such as cathinone, methcathinone, MDMA, and MDEA, including, but not limited to, any quantity of a natural or synthetic material, compound mixture, preparation, or substance which has a stimulate effect on the central nervous system. Upon banning, any of the following substances or substances which contain the described characteristics shall be considered a SYNTHETIC STIMULANT:
         (a)   3-Fluoromethcathinone;
         (b)   4-Fluoromethcathinone (other name: flephedrone);
         (c)   3,4-Methylenedioxymethcathinone (other name: methylone, MDMC);
         (d)   3,4-Methylenedioxypyrovalerone (other name: MDPV);
         (e)   4-Methylmethcathinone (other names: mephedrone, 4-MMC);
         (f)   4-Methoxymethcathinone (other names: methedrone, bk-PMMA, PMMC);
         (g)   4-Ethylmethcathinone (other name: 4-EMC);
         (h)   Ethcathinone;
         (i)   Beta-keto-N-methylbenzodioxyolylpropylamine (other names: butylone, bk-MBDB);
         (j)   Napthylpyrovalerone (other names: naphyrone, NRG-1);
         (k)   N,N-dimethylcathinone (other name: metamfepramone);
         (l)   Alpha-pyrrolidinopropiophenone (other name: alpha-PPP);
         (m)   4-methoxy-alpha-pyrrolidinopropiophenone (other name: MOPPP);
         (n)   3,4-methylenedioxy-alpha-pyrrolidinopropiophenone (other name: MDPPP);
         (o)   Alpha-pyrrolidinovalerophenone (other name: alpha-PVP);
         (p)   6,7-kihydro-5H-indeno(5,6-d)-1,3-dioxal-6-amine) (other name: MDAI); and
         (q)   Any compound that is structurally derived from 2-amino-1-phenyl-1-propanone by modification or substitution in any of the following ways:
            1.   In the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;
            2.   At the 3-position with an alkyl substituent;
            3.   At the nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups; or
            4.   By inclusion of the nitrogen atom in a cyclic structure.
(Prior Code, § 4-5-1)
   (B)   Unlawful sale of synthetic substances. It shall be unlawful for any person to sell, offer for sale, or deliver any product containing a synthetic cannabinoid or synthetic stimulant.
(Prior Code, § 4-5-2)
   (C)   Unlawful possession. It shall be unlawful to any person to knowingly possess a product containing a synthetic cannabinoid or synthetic stimulant.
(Prior Code, § 4-5-3)
(Ord. 726, passed 7-1-2013) Penalty, see § 112.99